Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy
1 other identifier
interventional
33
1 country
1
Brief Summary
To assess the feasibility and success of endoscopic ultrasound (EUS) directed biliary stone removal without use of fluoroscopy. Success for this study will be defined as the successful removal of all stones from the bile duct without the use of fluoroscopy. Fluoroscopy will only be used at the end of a presumed successful procedure to confirm that all stones are removed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 29, 2012
CompletedFirst Posted
Study publicly available on registry
September 5, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedJuly 26, 2016
July 1, 2016
2.8 years
August 29, 2012
July 25, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Successful removal of all stones from the bile duct without the use of fluoroscopy.
Up to 24 hours.
Study Arms (1)
Patients with common bile duct stones.
EXPERIMENTALCommon bile duct stone removal without fluoroscopy
Interventions
ERCP stone extraction technique without fluoroscopy involves: (1) catheter or catheter with wire access into the bile duct, (2) confirmation of biliary access with catheter aspiration of bile, (3) performance of endoscopic biliary sphincterotomy or balloon dilation to widen the bile duct opening to permit stone removal, (4) stone removal - number of stones seen on EUS should match the number removed.
Eligibility Criteria
You may qualify if:
- Patients able to give informed consent
- Patients referred to IES for the endoscopic evaluation and treatment of suspected bile duct stones
You may not qualify if:
- Patients with \>3 bile duct stones or with any stone \>12mm on EUS
- Patients with no bile duct stones on EUS
- Patients with altered biliary anatomy (periampullary diverticulum, anomalous pancreatibiliary junction, altered surgical anatomy)
- Patients who are pregnant or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- California Pacific Medical Center Research Institutelead
- University of California, Los Angelescollaborator
- Northwestern Universitycollaborator
Study Sites (1)
California Pacific Medical Center
San Francisco, California, 94115, United States
Related Publications (4)
Carr-Locke DL. Overview of the role of ERCP in the management of diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2002 Dec;56(6 Suppl):S157-60. doi: 10.1067/mge.2002.129023. No abstract available.
PMID: 12447259BACKGROUNDShelton J, Linder JD, Rivera-Alsina ME, Tarnasky PR. Commitment, confirmation, and clearance: new techniques for nonradiation ERCP during pregnancy (with videos). Gastrointest Endosc. 2008 Feb;67(2):364-8. doi: 10.1016/j.gie.2007.09.036.
PMID: 18226705BACKGROUNDMenees S, Elta G. Endoscopic retrograde cholangiopancreatography during pregnancy. Gastrointest Endosc Clin N Am. 2006 Jan;16(1):41-57. doi: 10.1016/j.giec.2006.01.004.
PMID: 16546022BACKGROUNDShah JN, Bhat YM, Hamerski CM, Kane SD, Binmoeller KF. Feasibility of nonradiation EUS-based ERCP in patients with uncomplicated choledocholithiasis (with video). Gastrointest Endosc. 2016 Nov;84(5):764-769. doi: 10.1016/j.gie.2016.03.1485. Epub 2016 Mar 31.
PMID: 27040099DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janak Shah, MD
California Pacific Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Pancreatic and Biliary Endoscopy
Study Record Dates
First Submitted
August 29, 2012
First Posted
September 5, 2012
Study Start
August 1, 2012
Primary Completion
June 1, 2015
Study Completion
March 1, 2016
Last Updated
July 26, 2016
Record last verified: 2016-07